NuVasive (NSDQ:NUVA) announced today that it launched its Reline 3D posterior fixation system for pediatric spinal deformities. San Diego-based NuVasive’s latest addition to its spine portfolio is now commercially available around the globe for treating adolescent idiopathic scoliosis (AIS). The Reline 3D is designed to turn a multi-step technique into a holistic, single-plane correction to offer […]
Nuvasive announces $400m offering
NuVasive (NSDQ:NUVA) announced that it intends to offer $400 million aggregate principal amount of convertible senior notes in a private offering. The San Diego-based spine technology company is offering the notes, due in 2023, as well as granting initial purchasers a 13-day option to purchase up to an additional $50 million in notes. According to a […]
NuVasive lands 2 510(k)s, launches spinal surgery device
NuVasive (NSDQ:NUVA) announced that it received FDA 510(k) clearance for its Modulus ALIF and Cohere TLIF-O offerings for thoracolumbar procedures. The San Diego-based company expanded its Advanced Materials Science (AMS) implant portfolio with the clearances, along with the commercial launch of the Modulus extreme lateral interbody fusion (XLIF) dual-sided plate. NuVasive’s Modulus anterior lumbar interbody fusion (ALIF) […]
NuVasive recalls scoliosis treatment devices
NuVasive (NSDQ:NUVA) issued an urgent field safety notice to warn users of an issue with the separation of a certain component in its Magec system model X rods. According to the safety notice, post-implant separation of an actuator end cap component was observed in the rods. Data from post-market surveillance revealed that the end cap separation […]
NuVasive prices $450m offering
NuVasive (NSDQ:NUVA) yesterday announced the pricing of a $450 million offering of convertible senior notes in a private placement. The offering consists of an aggregate principal amount of 0.375% convertible notes due in 2025. The San Diego-based spine technology company also granted initial purchasers a 13-day option to purchase up to an additional $50 million aggregate […]
NuVasive down despite doubled Q4 profits
NuVasive (NSDQ:NUVA) shares are down today despite fourth-quarter results that easily topped the consensus forecast and revealed more than double the profits compared to the same time last year. The San Diego-based spine technology company posted profits of $29.9 million, or 55¢ per share, on sales of $310.4 million for the three months ended Dec. 31, […]
NuVasive appoints new chief financial officer
NuVasive (NSDQ:NUVA) this week announced that it appointed Matthew Harbaugh as executive VP and chief financial officer, effective immediately. Harbaugh replaces Rajesh Asarpota, who is transitioning from the company. He has more than 25 years of experience in finance, business and strategy and operations management. Harbaugh will be responsible for overseeing all financial aspects of the […]
NuVasive gains on beat-n-raise Q3 numbers
NuVasive (NSDQ:NUVA) shares are up today after the spine implant maker reported beat-and-raise third-quarter results. San Diego-based NuVasive posted profits of $11.0 million, or 21¢ per share, on sales of $290.8 million for the three months ended Sept. 30, for a bottom-line slide of -30.9% on revenue growth of 20.2%. Adjusted to exclude one-time items, earnings […]
NASS 2019 roundup: NuVasive unveils Pulse robot and more
The 34th annual North American Spine Society Meeting took place last week in Chicago where orthopedic experts and medtech companies share data, research and the latest news in orthopedics. During this year’s meeting, NuVasive unveiled its Pulse robot that will allow surgeons to perform robotic-assisted spine surgery. Other companies touted pedicle screws, lumbar fusion and vertebral fracture […]
Alphatec CEO wins lawsuit against former employer NuVasive
Alphatec (NSDQ:ATEC) chairman & CEO Patrick Miles won summary judgment in a lawsuit filed by his former employer, NuVasive (NSDQ:NUVA), over his employment contract. Miles was chief operating officer of NuVasive when he left that company in October 2017 to take the reins at Alphatec. NuVasive sued Miles a week later, claiming that he enacted […]
NuVasive launches Modulus TLIF-A porous titanium implant
NuVasive (NSDQ:NUVA) yesterday announced the commercial launch of the Modulus TLIF-A, used in the transforaminal lumbar interbody fusion procedure. The Modulus TLIF-A is an anteriorly-placed porous titanium spine implant designed to promote bone in-growth and bone on-growth. “The Modulus TLIF-A system is the perfect synergy between optimized material properties and deliverability,” Dr. Jeffrey Gum, of […]
- 1
- 2
- 3
- …
- 23
- Next Page »
